drugset / Trial / NCT03475693

A Cohort Study Evaluating the Efficacy of PO Magnesium in the Treatment of Acute Traumatic Brain Injury in Adolescents

NCT03475693

RandomizedParallel-groupSingle-blindTreatment

Summary

The objective of this study is to evaluate the efficacy of magnesium in symptomatic reduction of mild traumatic brain injury in the adolescent population in the acute setting of injury.

Timeline

Start
2017-09-01
Primary completion
2019-11-30
Completion
2019-12-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Oxide Small molecule 400 mg Oral
Background Acetaminophen Small molecule 500 mg
Background Ondansetron Other / unclassified 4 mg Oral